Literature DB >> 11308295

Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes.

M C Miceli1, M Moran, C D Chung, V P Patel, T Low, W Zinnanti.   

Abstract

T cell receptor (TCR) antigen recognition induces the formation of a specialized 'immunological synapse' at the T cell : antigen presenting cell (APC) junction. This junction is generated by the recruitment and exclusion of particular proteins from the contact area and is required for T cell activation. We and others have hypothesized that lipid raft/non-raft partitioning provides a molecular basis for protein sorting which organizes the TCR, co-stimulators, signal transducers and the actin cytoskeleton at the T cell : APC interface. Here we discuss the emerging paradigm that co-stimulators induce the directional transport and clustering of lipid rafts at the T cell : APC interface, thus generating platform(s) specialized for processive and sustained TCR signal transduction and T cell activation. We also discuss recent data implicating the involvement of 'counter-stimulators' and other negative regulators which prevent optimal raft clustering at the TCR contact site and, thus, facilitate T cell inactivation and tolerance induction. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308295     DOI: 10.1006/smim.2000.0303

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  28 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.

Authors:  Sanjay Khandelwal; Paul A Roche
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

Review 3.  Functions of cell surface galectin-glycoprotein lattices.

Authors:  Gabriel A Rabinovich; Marta A Toscano; Shawn S Jackson; Gerardo R Vasta
Journal:  Curr Opin Struct Biol       Date:  2007-10-22       Impact factor: 6.809

4.  Local Cellular and Cytokine Cues in the Spleen Regulate In Situ T Cell Receptor Affinity, Function, and Fate of CD8+ T Cells.

Authors:  Young-Jin Seo; Prithiviraj Jothikumar; Mehul S Suthar; Cheng Zhu; Arash Grakoui
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

Review 5.  Lipid rafts and regulation of the cytoskeleton during T cell activation.

Authors:  Karina F Meiri
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

6.  Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation.

Authors:  Akira Togayachi; Yuko Kozono; Yuzuru Ikehara; Hiromi Ito; Nami Suzuki; Yuki Tsunoda; Sumie Abe; Takashi Sato; Kyoko Nakamura; Minoru Suzuki; Hatsumi M Goda; Makoto Ito; Takashi Kudo; Satoru Takahashi; Hisashi Narimatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function.

Authors:  Claudia C Motran; Karen M Molinder; Scot D Liu; Françoise Poirier; M Carrie Miceli
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

9.  Hypothesis: could the signalling function of membrane microdomains involve a localized transition of lipids from liquid to solid state?

Authors:  Etienne Joly
Journal:  BMC Cell Biol       Date:  2004-01-19       Impact factor: 4.241

10.  Gangliosides are important for the preservation of the structure and organization of RBL-2H3 mast cells.

Authors:  Adriana Maria Mariano Silveira e Souza; Edvaldo S Trindade; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.